Metraipolis › archive › dc_3930ffbafcb2

Atorvastatin Protects Against Deleterious Carfilzomib-Induced Transcriptional Changes in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes — Europe PMC PMID:41683782

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41683782
DOI
10.3390/ijms27031358
License (as archived)
solo-consultazione
Archived
2026-11-06T10:53:37.666Z
SHA-256 of the archived text
00ed35c3327490376750b87a7b0382de5d1afdc368912d6f64014420f8cbeb30
Stable URL of this page
https://metraipolis.com/documento/dc_3930ffbafcb2

How to cite

Atorvastatin Protects Against Deleterious Carfilzomib-Induced Transcriptional Changes in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes — Europe PMC PMID:41683782 — Europe PMC (en), https://europepmc.org/article/MED/41683782 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3930ffbafcb2 (Metraipolis archive dc_3930ffbafcb2, sha256 00ed35c3327490376750b87a7b0382de5d1afdc368912d6f64014420f8cbeb30)
BibTeX
@misc{dc3930ffbafcb2,
  title = {Atorvastatin Protects Against Deleterious Carfilzomib-Induced Transcriptional Changes in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes — Europe PMC PMID:41683782},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41683782},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3930ffbafcb2; sha256 00ed35c3327490376750b87a7b0382de5d1afdc368912d6f64014420f8cbeb30},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41683782. Agents can read the archived copy with the MCP tool read_document.